| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |